Finnish-Kenyan AIDS drug aims for global market

Business November 28, 2011

UCL, a Kenya-based drug manufacturer in Finnfund’s investment portfolio, is one of just a handful of African companies to have a medicine approved by WHO for sale on the global market.

But to win contracts with big buyers like Global Fund, Pepfar or Unicef, UCL must compete against Indian drug manufacturers.

If you are new to Development Today and would like to continue reading this article, send us a mail at subscribers@devtoday.no, including your name, title, organisation, and email contact, and you will receive a free Guest Pass, along with weekly updates.